Bellevue Life Sciences Acquisition Corp.(BLACU) - 2025 Q4 - Annual Report
For the transition period from to OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Registrant's telephone number, including area code: (425) 635-7700 (Former name or former address, if changed since last report) Securities registered pursuant to Section 12 ...